Confounding and indication for treatment in evaluation of drug treatment for hypertension

British Medical Journal

Volumn 315, Issue 7116, 1997, Pages 1151-1154

  Grobbee, Diederick E ^a   Hoes, Arno W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST;

ANGINA PECTORIS; ATHEROSCLEROSIS; CORONARY ARTERY BLOOD FLOW; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; HEART INFARCTION; HUMAN; HYPERTENSION; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SHORT SURVEY; SUDDEN DEATH; TREATMENT OUTCOME;

EID: 0030731208     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7116.1151     Document Type: Short Survey

References (33)

1. Miettinen OS. The need for randomization in the study of intended effects. Stat Med 1983;2:267-71.
2. Hoes AW, Grobbee DE, Lubsen J. Primary prevention in hypertension-valid conclusions from nonexperimental studies. Circulation 1991;84: V178-83.
3. Walker AM, Stampfer MJ. Observational studies on drug safety. Lancet 1996;348:489.
4. Psaty BM, Koepsell TD, Lo Gerfo JP, Wagner EH, Inui TS. Beta-blockers and primary prevention of coronary heart disease in patients with high blood pressure. JAMA 1989;261:2087-94.
5. Grobbee DE, Hoes AW. Xon potassium-sparing diuretics and risk of sudden cardiac death. J Hypertens 1995;13:1539-45.
6. Psaty BM, Heckbert SR, Koepsell TD, Siscovick DS, Raghunadian TE, Weiss NS, et al. The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA 1995 274;620-5.
7. Buring JE, Glynn RJ, Hennekens CH. Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested JAMA 1995;274:654-5.
8. Marwick C. PDA gives calcium channel blockers clean bill of health but warns of short acting nifedipine hazards. JAMA 1996;275:423.
9. Hoes AW Grobbee DE, Valkenburg HA, Lubsen J, Hofman A. Cardiovascular risk indicators and all cause mortality: a 12 year follow-up study in the Netherlands. Eur J Epidemiol 1993;9:285-92.
10. Merlo J, Ranstam J, Liedholm H, Hedblad B, Lindberg G, Lindblad U, et al. Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort study. BMJ 1996;313:457-61.
11. Raj ala S, Haavisto M, Heikinheimo R, Matilla K. Blood pressure and mortality in the very old. Lancet 1983;ii:520-1.
12. Langer RD, Ganiats TG, Barrett-Connor E. Paradoxical survival of elderly men with high blood pressure. BMJ 1989;298:1356-7.
13. Taylor JO, Cornoni-Huntley J, Curb JD, Manton KG, Ostfeld AM, Scherr P, et al. Blood pressure and mortality risk in the elderly. Am J Epidemiol 1991;134:489-504.
14. Coope J, Warrender TS, McPherson K. The prognostic significance of blood pressure in the elderly. J Hum Hypertens 1988;2:79-88.
15. Staessen J, Bulpitt C, Clement D, De Leeuw P, Fagard R, Fletcher A, et al. Relation between mortality and treated blood pressure in elderly patients with hypertension: Report of the European Working Party on High Blood Pressure in the Elderly. BMJ 1989;298:1552-6.
16. Stewart IMcDG. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1979;i:861-5.
17. McCruishank JM, Thorp JM, Zacharias FJ. Benefits and potential harms of lowering high blood pressure. Lancet 1987;i:581-4.
18. Lindblad U, Rastam L, Ryden L, Ranstam J, Isacsson SO, Berglund G. Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project. BMJ 1994;308:681-6.
19. Fletcher AK, Beevers DG, Bulpitt CJ, Butler A, Coles EC, Hunt D, et al. The relationship between a low treated blood pressure and JHD mortality: a report of the DHSS Hypertension Care Computing Project J Hum Hypertens 1988;2:11-5.
20. Samuelsson OG, Wilhelmsen LW, Pennert KM, Wedel H, Berglund GL. The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the primary prevention trial in Gothenburg, Sweden. J Hypertens 1990;8:547-55.
21. Cruickshank JM. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. BMJ 1988;297:1227-30.
22. Alderman MH, Ooi LVL, Madhavan S, Cohen H. Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA 1989;262:920-24.
23. Farnett L, Mulrow CD, Linn WD, Lucey CR, Tuley MR. The J-shaped phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA 1991;26:489-95.
24. Zanchetti A, Amery A, Berglund G, Cruickshank JM, Hansson L, Lever AF, et al. How much should blood pressure be lowered. The problem of the J-shaped curve. J Hypertension 1989;7(suppl 6):S338-48.
25. Flechter AK, Bulpitt CJ. How far should blood pressure be lowered. N Engl J Med 1992;326:251-4.
26. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H et al. Effect on diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996;276:1886-92.
27. Sleight P. Blood pressures, hearts, and U-shaped curves. Lancet 1988;i:235.
28. Mirai T, Sasayama S, Kawasaki T, Yagi S. Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation 1989;80:78-86.
29. Arnett DK, Evans GW, Riley WA. Arterial stiffness: a new cardiovascular risk factor. Am J Epidemiol 1994;140:669-82.
30. Witteman JCM, Grobbee DE, Valkenburg HA, Hemert AM van, Stijnen T, Burger H, Hofman. A J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet 1994;343:504-7.
31. Bots ML, Witteman JCM, Hofman A, de Jong PTVM, Grobbee DE. Low diastolic blood pressure and atherosclerosis in the elderly. The Rotterdam study. Arch Intern Med 1996;156:843-8.
32. Simon JA Treating hypertension: the evidence from clinical trials. BMJ 1996;313:437-8.
33. Hansson L, Zanchetti A. The hypertension optimal treatment (HOT) study: 12-month data on blood pressure and tolerability. With special reference to age and gender. Blood Pressure 1995;4:313-9.